Skip over main navigation
  • Log in
  • Basket: (0 items)
  • Perth Blood Institute
  • Thrombosis Australia
  • Thrombosis Australia Professionals
Perth Blood Institute
  • Search
  • Facebook
  • Linkedin
  • Email
  • Search
  • Facebook
  • Linkedin
  • Email
Login Register Subscribe Donate
Menu
  • About us
    • Vision, mission and values
    • What we do
    • Our facilities
    • Our team
      • Board
      • Investigators
    • Work with us
  • Clinical trials
    • Our clinical trials
    • Study experience
    • Start up processes
    • West Perth facilities
    • Ethics & governance
  • Current research projects
    • Current research projects
    • Research highlights
    • Research collaborations
      • PBI
      • APTIN
    • Participate in a research project
    • Published research
  • About blood disorders
    • Overview
    • Blood disorders
      • Anaemia
      • Antiphospholipid syndrome (APS)
      • Haemophilia
      • ITP
      • Polycythemia vera
      • Protein C and S deficiency
      • Sickle cell disease
      • Thrombocythaemia
      • Thrombophilia
      • TTP
      • von Willebrand Disease
    • Blood cancers
      • Chronic lymphocytic leukaemia
      • Leukaemia
      • Lymphoma
      • Multiple myeloma
      • Myelofibrosis (MF)
    • For patients and families
  • Stories
    • Living with a blood disorder
  • Get involved
    • Donate
    • Fundraise
    • Leave a gift in your will
    • Other ways to help
  • News and events
    • News and information
    • Significant days
      • 2024
      • 2023
      • 2022
    • Media
    • Publications
  • Admin
    • Log in
    • Perth Blood Institute
    • Thrombosis Australia
    • Thrombosis Australia Professionals
  • Basket: (0 items)
  • Thrombophilia
  1. About blood disorders
  2. Blood disorders

Thrombophilia

Thrombophilia is an abnormal coagulation process which can be inherited or acquired. It results in a hypercoagulable state and increases the risk of thrombotic events where blood clots can form in either the arteries or veins. It is more common to acquire thrombophilia as the causes include trauma, surgery, immobilisation, pregnancy, hormone replacement therapy, and the use of oral contraceptives.

Research into hereditary thrombophilia started by studying families with a history of venous thromboembolism. The two most common causes of genetic related thrombophilia are elevated coagulation factors ‘prothrombin gene mutation’ and ‘factor V Leiden’ (FVL). These account for up 70% of diagnosed inherited forms of thrombophilia.

FVL is a mutation of one of the blood clotting factors which can increase the chance of developing abnormal blood clots. These thrombi commonly occur in the legs or lungs and can lead to long-term health problems or be life-threatening. As mentioned above, women who carry the FVL mutation may have an increased tendency to develop blood clots during pregnancy or when using HRT or oral contraceptives. 

Research has shown that FVL has been associated with pregnancy complications linked to hypercoagulation. There is an 8-fold risk increase with DVT, a 26% increased possibility of pre-eclampsia, and an increased prevalence of 31% for second and third trimester pregnancy failure.

Recently PBI was contacted by Tiffany who has FVL associated Thrombophilia. You can read her story HERE.

For additional information about thrombophilia please click HERE.

A review by the American Society of Hematology published 2023 Guidelines for the Management of venous thromboembolism related to thrombophilia testing.

References

  • Samfireag, M. et al., (2022). Approach to Thrombophilia in Pregnancy—A Narrative Review. Medicina
  • Thrombophilia and their detection - ScienceDirect
  • Factor V Leiden - Symptoms and causes - Mayo Clinic
  • Spina, V., Aleandri, V., & Morini, F. (2000). The impact of the factor V Leiden mutation on pregnancy. Human Reprod Update. doi: 10.1093/humupd/6.3.301.

Published: 16th August, 2022

Updated: 5th December, 2023

Author: Gina Rodgers

Share this page
  • Email
  • Facebook
  • Twitter

Tag cloud

Acute Myeloid Leukaemia ADAMTS13 blood clots cancer contraceptive Follicular Lymphoma haemophilia A Microangiopathic Thrombocytopenia multiple myeloma oral contraceptive pregnancy Relapsed Multiple Myeloma small vessels thrombosis Thrombotic Thrombocytopaenic Pupura TMA

Sign up for our newsletter

Please enter your first name
Please enter your last name
Please enter your email address Please enter a valid email address (e.g. [email protected])

Helpful links

  • Sitemap
  • Accessibility
  • Terms & conditions
  • Privacy policy
  • Contact us

Contact

18 Prowse Street
West Perth
WA 6005
P : +61 8 9200 5300
F : +61 8 9200 5324
E : [email protected]

  • Facebook
  • Instagram
  • Linkedin
  • Email

PBI is registered as an Income Tax Exempt Charity
CFN: CC21886
ACN: 164 941 815
ABN: 24 164 941 815

© Perth Blood Institute 2020